Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Gains from Investment Securities (2017 - 2026)

Kewaunee Scientific has reported Gains from Investment Securities over the past 6 years, most recently at $17000.0 for Q1 2026.

  • Quarterly results put Gains from Investment Securities at $17000.0 for Q1 2026, up 30.77% from a year ago — trailing twelve months through Jan 2026 was $15000.0 (down 93.06% YoY), and the annual figure for FY2025 was $6000.0, down 97.0%.
  • Gains from Investment Securities for Q1 2026 was $17000.0 at Kewaunee Scientific, down from $72000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for KEQU hit a ceiling of $122000.0 in Q2 2024 and a floor of -$88000.0 in Q2 2025.
  • Median Gains from Investment Securities over the past 3 years was $15500.0 (2025), compared with a mean of $28875.0.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 172.13% in 2025 and later surged 30.77% in 2026.
  • Kewaunee Scientific's Gains from Investment Securities stood at $70000.0 in 2024, then rose by 2.86% to $72000.0 in 2025, then tumbled by 76.39% to $17000.0 in 2026.
  • The last three reported values for Gains from Investment Securities were $17000.0 (Q1 2026), $72000.0 (Q4 2025), and $14000.0 (Q3 2025) per Business Quant data.